Impact of garlic tablets on nosocomial infections in hospitalized patients in intensive care units
Keywords:
Garlic, Iatrogenic disease, Complementary and alternative medicine, Communicable diseaseAbstract
Background: Nosocomial infections are one of the main causes of mortality and morbidity in hospitals, especially in intensive care units (ICUs).
Objective: The aim of this study was to examine the impact of garlic tablets on nosocomial infections in hospitalized patients in intensive care units.
Methods: This clinical trial was carried out on 94 patients, admitted to the intensive care units in Kashani and Al-Zahra hospitals from January 21, 2014 to December 20, 2014. Firstly, the patients were randomly selected by simple sampling, then they were assigned into case and control groups. The case group administered one 400 mg garlic tablet daily for 6 days and the control group received placebo. During the study, inflammatory blood factors and infection occurrence in the two groups were compared. The Data were analyzed by SPSS software version 22 through descriptive tests such as independent t-test, Chi-square test, ANOVA and exact Fisher test for the analyses of primary and secondary outcomes.
Results: During the study period, 78 cases of intravenous catheter tip were sent to laboratory for culture, of which, 37 cases were in the intervention group and 41 in the control group. Culture results of Catheter tips was positive in 5 cases and all five cases were in the control group. Frequency distribution of catheter tip culture was significantly higher in the control group than that of the intervention group (p=0.03).
Conclusion: Based on the results of our study, in people with weakened immune systems and in people with high incidence of opportunistic infections, it is necessary to strengthen their body's immune system stimulants before dealing with these infectious agents, and cause decrease in the diseases insusceptible people. It was suggested that garlic supplementation has shown to be effective in patients admitted to ICU, who are highly susceptible to nosocomial infection, and it can be used for the prevention of septicemia and urinary tract infections. However, further research with larger sample size is needed.
Trial registration: The trial was registered at the Iranian Registry of Clinical Trials (http://www.irct.ir) with the Irct ID: IRCT207406156480N6.
Funding: Shahrekord University of Medical Sciences financially supported this research.
References
Robert P Gaynes. Surveillance of Nosocomial Infections. In: John V. Bennett Philip S. Brachman, ed. Hosp
Infect, 4th edition, U.S.A: Lippincott-Raven; 1998; 65-84.
Weinstein RA. Hosptial acquired infections In: Harrison principles of internal medicine. 16th ed. USA; Mc
Graw Hill. 2005; 775-81.
Edmond MB, Wenzel RP. Nosocomial Infection In: Principles and Practice of Infectious Diseases. Mandell
GL, Bennett JE, Dolin R, editors. 16th ed. New York: Churchill livingstone; 2005: 2362-3380.
Agarwal M, Thomas P. Nurse J India. 2003; 94(9): 197-8.
Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site
infections, 1992: a modification of CDC definition of surgical wound infections. Infect Control Hosp
Epidemiol. 1992; 13(10): 606–8. PMID: 1334988.
Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988.
Am J Infect Control. 1988; 16: 128-40. doi: 10.1016/0196-6553(88)90053-3.
Mayon-White RT, Ducel G, Kereselidze T, Tikomirov E. An international survey of the prevalence of
hospital-acquired infection. J Hosp Infect. 1988; 11(suppl A): 43–8. doi: 10.1016/0195-6701(88)90164-8.
PMID: 2896744.
Tikhomirov E. WHO Programme for the Control of Hospital Infections. Chemiotherapia. 1987; 3: 148–51.
Charles Muskins W, Goldman D. Nosocomial infections. In: Feigen RD, Cherryjames D, Demmler GJ,
Kaplan L. Textbook of pediatrics infections disease. 5th ed. New York: Elsevier; 2004: 2875-82.
Barbara J. Stoll infection of Neonatal infects. In: Kliegman R, Richard E. Nelson textbook of pediatrics,
th ed. ENGLISH: sandres; 2007: 798-9.
Abdollahi A, Rahmani H, Khodabakhshi B, Behnampour N. Assessment of level of knowledge, attitude
and practice of employed nurses to nosocomial infection in teaching hospitals of Golestan University of
Medical Sciences (2000). J Gorgan Univ Med Sci. 2003; 5(1): 80-6.
Sheng WH, Wang JT, Lin MS, Chang SC. Risk factors affecting in-hospital mortality in patients with
nosocomial infections. J Formos Med Assoc. 2007; 106(2): 110-8. doi: 10.1016/S0929-6646(09)60226-6.
PMID: 17339154.
Kampf G, Gastmeier P, Wischnewski N, Schlingmann J, Schumacher M, Daschner F, et al. Analysis of risk
factors for nosocomial infections result from the first national prevalence survey in Germany (NIDEP
study, part 1). J Hosp Infec. 1997; 37(2): 103-12. doi: 10.1016/S0195-6701(97)90180-8. PMID: 9364259.
Smyth ET, Emmerson AM. Surgical site infection surveillance. J Hospital infect. 2000; 45(3): 173-84. doi:
1053/jhin.2000.0736. PMID: 10896795.
Shintani H, Hayashi F, Sakakibara Y, Kurosu S, Miki A, Furukawa T. Relationship between the
contamination of the nurse's caps and their period of use in terms of microorganism numbers. Biocontrol
sci. 2006; 11(1): 11-6. PMID: 16637434.
Brunner LS, Smeltzer SC. Brunner & Suddarth’s textbook of medical-surgical nursing. 12th ed.
Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins; 2010.
Vosylius S, Sipylaite J, Vaskevicius I. Intensive care unit acquired infection: a prevalence and impact on
morbidity and mortality. Acta Anaesth Scand. 2003; 47(9): 1132-37. doi: 10.1034/j.1399- 6576.2003.00230.x. PMID: 12969108.
Echols RM, Tosiello RL, Haverstock DC, Tice AD. Demographic, clinical and treatment parameters
influencing the outcome of acute cystitis. Clin Infect Dis. 1999; 29: 113–9. doi: 10.1086/520138. PMID:
Mulvey MA, Schilling JD, Jultgren SJ. Establishment of a persistent Escherichia coli reservoir during the
acute phase of a bladder infection. Infect Immun. 2001; 69: 4572–9. doi: 10.1128/IAI.69.7.4572- 4579.2001. PMID: 11402001, PMCID: PMC98534.
Rosen DA, Hooten TM, Stamm WE, Humphrey PA, Hultgren SJ. Detection of intracellular bacterial
communities in human urinary tractinfection. PLOS Med. 2007; 4(12): e329. doi:
1371/journal.pmed.0040329. PMID: 18092884, PMCID: PMC2140087.
Kaoutar B, Joly C, Heriteau FL, Barbut F. Nosocomial infections and hospital mortality: a multicenter
epidemiological study. J Hosp infec. 2004; 58: 268-75. doi: 10.1016/j.jhin.2004.06.006.
Bayan L, Koulivand PH, Gorji A. Garlic: a review of potential therapeutic effects. Avicenna J Phytomed.
; 4(1): 1-14. PMID: 25050296, PMCID: PMC4103721.
Soleimani D, Paknahad Z, Askari G, Iraj B, Feizi A. Effect of garlic powder consumption on body
composition in patients with nonalcoholic fatty liver disease: A randomized, double-blind, placebo- controlled trial. Adv Biomed Res. 2016; 5: 2. doi: 10.4103/2277-9175.174962. PMID: 26955623, PMCID:
PMC4763563.
Kojuri J, Vosoughi AR, Akrami M. Effects of anethum graveolens and garlic on lipid profile in
hyperlipidemic patients. Lipids Health Dis. 2007; 6: 5. doi: 10.1186/1476-511X-6-5. PMID: 17328819,
PMCID: PMC1821028.
Cai Y, Wang R, Pei F, Liang BB. Antibacterial Activity of Allicin Alone and in Combination with [beta]- Lactams against Staphylococcus spp. and Pseudomonas aeruginosa. J Antibiot (Tokyo). 2007; (60)5: 335- 8. doi: 10.1038/ja.2007.45. PMID: 17551215.
Tsao S, Yin M. Invitro activity of garlic oil and four diallylsulphides against antibiotic-resistant
pseudomonas aeruginosa and Klebsiella pneumoniae. J Antimicrob Chemother. 2001; 47(5): 665-70. doi:
1093/jac/47.5.665. PMID: 11328781.
Dikasso D, Lemma H, Urga K, Debella A, Addis G, Tadele A, et al. Investigation on the antibacterial
properties of garlic (Allium sativum) on pneumonia causing bacteria. Ethiop Med J. 2002; 40(3): 241-9.
PMID: 12602248.
Dankert J, Tromp TF, De Vries H, Klasen HJ. Antimicrobial activity of crude juices of Allium
ascalonicum, Alliumcepa and Allium sativum. Zentralbl Bakteriol Orig A. 1979; 245(1-2): 229-39. PMID:
Josling P. Preventing the common cold with a garlic supplement: a double-blind, placebo-controlled
survey. Adv Ther. 2001; 18(4): 189-93. PMID: 11697022.
Elnima FI, Ahmed SA, Mckkawi AG, Mossa JS. The antimicrobial activity of garlic and onion extracts.
Pharmazie. 1983; 38(11):747-8. PMID: 6669596.
Alice D, Sivaprakasam K. Antibiotics and garlic clove extract--inhibitory agents of cell wall degrading
enzymes. Hindustan Antibiot bull. 1995; 37(1-4): 44-7.
Fang F, Li H, Cui W, Dong Y. Treatment of hepatitis caused by cytomegalovirus with allitridin injection-- an experimental study. J Tongji Med Univ. 1999; 19: 271-4. doi: 10.1007/BF02886960. PMID: 12938515.
Resch KL, Ernst E. [Garlic (Allium sativum)--a potent medicinal plant]. Fortschr Med. 1995; 113(20-21):
-5. PMID: 7557803.
Singh UP, Prithiviraj B, Sarma BK, Singh M, Ray AB. Role of garlic (Allium sativum L.) in human and
plant diseases. Indian J Exp Biol. 2001; 39(4): 310-22. PMID: 11491574.
Arora DS, Kaur J. Antimicrobial activity of spices. Int J Antimicrob Agent. 1999; 12(3): 257-62. doi:
1016/S0924-8579(99)00074-6. PMID: 10461845.
Published
Issue
Section
License
Copyright (c) 2020 KNOWLEDGE KINGDOM PUBLISHING
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
